Profil
Matthew W.
Onaitis is currently Director at Snp Bio, Inc. and Stratify Genomics, Inc., and Chief Financial Officer at Mainstay Medical International Ltd. since 2018.
Formerly, Mr. Onaitis was Director-Legal Affairs at Elan Corp.
Plc (2004-2005), Associate General Counsel at Biogen, Inc. (2006), Secretary, Senior Vice President & General Counsel at Somaxon Pharmaceuticals, Inc. (2010-2013), Secretary & General Counsel at Trius Therapeutics, Inc. (2013), Secretary & General Counsel at Ignyta, Inc. (2014-2016), and CFO, Secretary, CAO & General Counsel at Cidara Therapeutics, Inc. (2016-2018).
Education includes an undergraduate degree from Carnegie Mellon University (1993) and a graduate degree from Stanford Law School (1998).
Aktive Positionen von Matthew Onaitis
| Unternehmen | Position | Beginn |
|---|---|---|
| MAINSTAY MEDICAL INTERNATIONAL | Finanzdirektor/CFO | 20.08.2018 |
Snp Bio, Inc. | Direktor/Vorstandsmitglied | - |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Matthew Onaitis
| Unternehmen | Position | Ende |
|---|---|---|
| CIDARA THERAPEUTICS | Finanzdirektor/CFO | 17.08.2018 |
| IGNYTA INC | General Counsel | 01.06.2016 |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | General Counsel | 01.12.2013 |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | General Counsel | 01.03.2013 |
| BIOGEN INC. | Corporate Officer/Principal | 01.05.2006 |
Ausbildung von Matthew Onaitis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Biogen, Inc.
Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Somaxon Pharmaceuticals, Inc.
Somaxon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products | Health Technology |
Mainstay Medical International Ltd.
Mainstay Medical International Ltd. Medical SpecialtiesHealth Technology Develops neurostimulation therapies for people with chronic mechanical low back pain | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Ignyta, Inc.
Ignyta, Inc. BiotechnologyHealth Technology Operates as a medicine biotechnology company which provides new drugs services for cancer patients | Health Technology |
Stanford Law School
Stanford Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cidara Therapeutics, Inc.
Cidara Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Engages in the discovery, development, and commercialization of novel anti-infectives | Health Technology |
Snp Bio, Inc. | |
Stratify Genomics, Inc.
Stratify Genomics, Inc. Medical/Nursing ServicesHealth Services Operates as a cancer risk stratification company | Health Services |
















